Home › Companies › Vaxcyte, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Vaxcyte, Inc.’s Form 8-K, filed June 16, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 15, 2026: 5 items on Vaxcyte, Inc.’s Form 8-K, filed June 16, 2026: 2 approved · 3 passed (calculated).
Notable dissent: 2 directors (13.8%, 12.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Ra Capital Management, L.P. (13F, 7.2%, as of September 30, 2026) · Caligan Partners (13F, 1.4%, as of September 30, 2026)
Explore Vaxcyte, Inc. in the interactive database Compare manager voting policies
These tallies are Vaxcyte, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 16, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Olivier Brandicourt, M.D. | 116,370,183 | -- | -- | 16,643,897 | 4,354,403 | 87% | Passed (calculated) | — |
| Elect Director: Halley Gilbert, J.D. | 114,704,274 | -- | -- | 18,309,806 | 4,354,403 | 86% | Passed (calculated) | — |
| Elect Director: Grant Pickering, M.B.A. | 132,112,840 | -- | -- | 901,240 | 4,354,403 | 99.3% | Passed (calculated) | — |
| 2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 | 137,230,032 | 137,589 | 862 | -- | -- | 99.9% | Approved | — |
| 3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers | 130,011,017 | 2,755,868 | 247,195 | -- | 4,354,403 | 98% | Approved | — |
Source: Vaxcyte, Inc., Form 8-K, filed with the SEC on June 16, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
349 asset managers disclosed a vote on at least one Vaxcyte, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D.
Vaxcyte, Inc.’s own tally for this item (“Elect Director: Olivier Brandicourt, M.D.”): 116,370,183 for, 16,643,897 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 67,002,205 for, 2,323,684 withheld, 1,104,841 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,758,851 | 0 | 0 | 1,200 | For |
| Vanguard | 15,629,465 | 0 | 34 | 0 | For |
| JANUS INVESTMENT FUND | 8,778,700 | 0 | 0 | 130,463 | For |
| T. Rowe Price | 7,896,178 | 0 | 0 | 0 | For |
| BlackRock | 5,381,969 | 0 | 0 | 0 | For |
| State Street | 1,686,364 | 0 | 0 | 16,237 | For |
| Charles Schwab | 1,403,438 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,367,753 | 0 | 0 | 0 | For |
| Jackson National | 939,328 | 0 | 132,069 | 0 | Mixed |
| Capital Group | 912,688 | 0 | 0 | 0 | For |
| Prudential/PGIM | 836,471 | 0 | 0 | 540 | For |
| HARBOR FUNDS | 0 | 0 | 811,895 | 0 | Abstain |
| JPMorgan | 573,638 | 0 | 0 | 0 | For |
| Federated Hermes | 538,085 | 0 | 0 | 0 | For |
| Victory Capital | 567 | 0 | 0 | 484,972 | Withhold |
| Equitable | 376,188 | 0 | 0 | 92,529 | Mixed |
| JANUS ASPEN SERIES | 339,889 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 277,976 | Withhold |
| TIAA | 261,821 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 256,531 | Withhold |
| Bridge Builder Trust | 248,308 | 0 | 0 | 0 | For |
| Hartford | 238,418 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 228,519 | Withhold |
| John Hancock | 135,108 | 0 | 92,947 | 0 | Mixed |
| Voya | 223,225 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Halley Gilbert, J.D.
Vaxcyte, Inc.’s own tally for this item (“Elect Director: Halley Gilbert, J.D.”): 114,704,274 for, 18,309,806 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 66,704,694 for, 2,621,194 withheld, 1,104,842 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,758,851 | 0 | 0 | 1,200 | For |
| Vanguard | 15,622,393 | 0 | 35 | 7,071 | For |
| JANUS INVESTMENT FUND | 8,778,700 | 0 | 0 | 130,463 | For |
| T. Rowe Price | 7,896,178 | 0 | 0 | 0 | For |
| BlackRock | 5,381,969 | 0 | 0 | 0 | For |
| State Street | 1,686,364 | 0 | 0 | 16,237 | For |
| Charles Schwab | 1,403,438 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,367,753 | 0 | 0 | 0 | For |
| Jackson National | 939,328 | 0 | 132,069 | 0 | Mixed |
| Capital Group | 912,688 | 0 | 0 | 0 | For |
| Prudential/PGIM | 836,471 | 0 | 0 | 540 | For |
| HARBOR FUNDS | 0 | 0 | 811,895 | 0 | Abstain |
| JPMorgan | 573,638 | 0 | 0 | 0 | For |
| Federated Hermes | 538,085 | 0 | 0 | 0 | For |
| Victory Capital | 567 | 0 | 0 | 484,972 | Withhold |
| Equitable | 376,188 | 0 | 0 | 92,529 | Mixed |
| JANUS ASPEN SERIES | 339,889 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 277,976 | Withhold |
| TIAA | 261,821 | 0 | 0 | 0 | For |
| ALGER FUNDS | 0 | 0 | 0 | 256,531 | Withhold |
| Bridge Builder Trust | 248,308 | 0 | 0 | 0 | For |
| Hartford | 238,418 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 228,519 | Withhold |
| John Hancock | 135,108 | 0 | 92,947 | 0 | Mixed |
| Voya | 0 | 0 | 0 | 223,225 | Withhold |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Grant E. Pickering, M.B.A.
Vaxcyte, Inc.’s own tally for this item (“Elect Director: Grant Pickering, M.B.A.”): 132,112,840 for, 901,240 withheld, per its Form 8-K filed June 16, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 93 asset managers below reported 70,113,523 for, 237,590 withheld, 79,617 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,760,051 | 0 | 0 | 0 | For |
| Vanguard | 15,629,497 | 0 | 2 | 0 | For |
| JANUS INVESTMENT FUND | 8,909,163 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,896,178 | 0 | 0 | 0 | For |
| BlackRock | 5,381,969 | 0 | 0 | 0 | For |
| State Street | 1,702,601 | 0 | 0 | 0 | For |
| Charles Schwab | 1,403,438 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,367,753 | 0 | 0 | 0 | For |
| Jackson National | 1,053,252 | 0 | 18,145 | 0 | For |
| Capital Group | 912,688 | 0 | 0 | 0 | For |
| Prudential/PGIM | 836,471 | 0 | 0 | 540 | For |
| HARBOR FUNDS | 811,895 | 0 | 0 | 0 | For |
| JPMorgan | 573,638 | 0 | 0 | 0 | For |
| Federated Hermes | 538,085 | 0 | 0 | 0 | For |
| Victory Capital | 485,539 | 0 | 0 | 0 | For |
| Equitable | 376,188 | 0 | 0 | 92,529 | Mixed |
| JANUS ASPEN SERIES | 339,889 | 0 | 0 | 0 | For |
| American Century | 277,976 | 0 | 0 | 0 | For |
| TIAA | 261,821 | 0 | 0 | 0 | For |
| ALGER FUNDS | 256,531 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 248,308 | 0 | 0 | 0 | For |
| Hartford | 238,418 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 228,519 | 0 | 0 | 0 | For |
| John Hancock | 166,585 | 0 | 61,470 | 0 | Mixed |
| Voya | 223,225 | 0 | 0 | 0 | For |
Showing the 25 largest of 93 asset managers. All 93 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 63.7% for (June 12, 2025 meeting) ▲ 34.2 pts
Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.
Vaxcyte, Inc.’s own tally for this item (“3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers”): 130,011,017 for, 2,755,868 against — passed, per its Form 8-K filed June 16, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The approval of the non-binding resolution on named executive officer compensation was approved by the votes indicated:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Vaxcyte, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “SAY ON PAY” (2 managers, 54 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,760,051 | 0 | 0 | 0 | For |
| Vanguard | 15,610,499 | 18,999 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 8,909,163 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,791,173 | 105,005 | 0 | 0 | For |
| BlackRock | 5,381,969 | 0 | 0 | 0 | For |
| State Street | 1,700,499 | 2,102 | 0 | 0 | For |
| Charles Schwab | 1,403,438 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,367,753 | 0 | 0 | 0 | For |
| Jackson National | 1,071,397 | 0 | 0 | 0 | For |
| Capital Group | 0 | 912,688 | 0 | 0 | Against |
| Prudential/PGIM | 832,111 | 4,900 | 0 | 0 | For |
| HARBOR FUNDS | 811,895 | 0 | 0 | 0 | For |
| JPMorgan | 573,638 | 0 | 0 | 0 | For |
| Federated Hermes | 538,085 | 0 | 0 | 0 | For |
| Victory Capital | 485,539 | 0 | 0 | 0 | For |
| Equitable | 468,717 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 339,889 | 0 | 0 | 0 | For |
| American Century | 277,976 | 0 | 0 | 0 | For |
| TIAA | 261,821 | 0 | 0 | 0 | For |
| ALGER FUNDS | 256,531 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 248,308 | 0 | 0 | 0 | For |
| Hartford | 238,418 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 228,519 | 0 | 0 | 0 | For |
| John Hancock | 228,055 | 0 | 0 | 0 | For |
| Voya | 223,225 | 0 | 0 | 0 | For |
Fund voting reports, all 92 managers: 69,300,959 for, 1,128,836 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 25,385,690 | 0 | 0 | 0 | For |
| Fidelity | 16,805,589 | 0 | 0 | 0 | For |
| T. Rowe Price | 12,679,694 | 156,043 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 11,474,599 | 0 | 0 | 0 | For |
| Wellington | 5,043,516 | 0 | 0 | 0 | For |
| BlackRock | 4,421,739 | 0 | 0 | 0 | For |
| State Street | 4,192,870 | 2,553 | 0 | 0 | For |
| Deep Track Capital, LP | 4,080,248 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 3,235,381 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,223,717 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 2,692,450 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 1,975,153 | Withhold |
| Charles Schwab | 1,411,495 | 0 | 0 | 0 | For |
| DE Shaw | 1,295,312 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 1,095,689 | 4,606 | 0 | 0 | For |
| Vanguard | 1,065,807 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | 0 | 0 | 0 | For |
| Northern Trust | 987,578 | 0 | 0 | 0 | For |
| Aberdeen | 928,933 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 912,688 | 0 | 0 | Against |
| Paradigm Biocapital Advisors LP | 829,655 | 0 | 0 | 0 | For |
| Baupost | 800,000 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 800,000 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 754,036 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 747,162 | 0 | 0 | 0 | For |
Institutional-manager reports, all 284 managers: 115,842,800 for, 2,180,765 against, 1,975,153 withheld, 3,840 not voted. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 99.8% for (June 12, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Vaxcyte, Inc.’s own tally for this item (“2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 137,230,032 for, 137,589 against — passed, per its Form 8-K filed June 16, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The appointment was ratified by the votes indicated:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 94 asset managers below reported 70,430,834 for, 66 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,760,051 | 0 | 0 | 0 | For |
| Vanguard | 15,629,499 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 8,909,163 | 0 | 0 | 0 | For |
| T. Rowe Price | 7,896,178 | 0 | 0 | 0 | For |
| BlackRock | 5,381,969 | 0 | 0 | 0 | For |
| State Street | 1,702,535 | 66 | 0 | 0 | For |
| Charles Schwab | 1,403,438 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 1,367,753 | 0 | 0 | 0 | For |
| Jackson National | 1,071,397 | 0 | 0 | 0 | For |
| Capital Group | 912,688 | 0 | 0 | 0 | For |
| Prudential/PGIM | 837,011 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 811,895 | 0 | 0 | 0 | For |
| JPMorgan | 573,638 | 0 | 0 | 0 | For |
| Federated Hermes | 538,085 | 0 | 0 | 0 | For |
| Victory Capital | 485,539 | 0 | 0 | 0 | For |
| Equitable | 468,717 | 0 | 0 | 0 | For |
| JANUS ASPEN SERIES | 339,889 | 0 | 0 | 0 | For |
| American Century | 277,976 | 0 | 0 | 0 | For |
| TIAA | 261,821 | 0 | 0 | 0 | For |
| ALGER FUNDS | 256,531 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 248,308 | 0 | 0 | 0 | For |
| Hartford | 238,418 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 228,519 | 0 | 0 | 0 | For |
| John Hancock | 228,055 | 0 | 0 | 0 | For |
| Voya | 223,225 | 0 | 0 | 0 | For |
Showing the 25 largest of 94 asset managers. All 94 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 144,397,682 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.61% |
| 2 | Vanguard | 10.82% |
| 3 | JANUS INVESTMENT FUND | 6.17% |
| 4 | T. Rowe Price | 5.47% |
| 5 | BlackRock | 3.73% |
| 6 | State Street | 1.18% |
| 7 | Charles Schwab | 0.97% |
| 8 | MUTUAL FUND SERIES TRUST | 0.95% |
| 9 | Jackson National | 0.74% |
| 10 | Capital Group | 0.63% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 17.58% |
| 2 | Fidelity | 11.64% |
| 3 | T. Rowe Price | 8.89% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 7.95% |
| 5 | Wellington | 3.49% |
| 6 | BlackRock | 3.06% |
| 7 | State Street | 2.91% |
| 8 | Deep Track Capital, LP | 2.83% |
| 9 | WESTFIELD CAPITAL MANAGEMENT CO LP | 2.24% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.23% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 16,575,875 | 11.48% | Schedule 13G, filed May 15, 2026 |
| FMR (Fidelity) | 16,492,861 | 11.42% | Form 13F, quarter ended March 31, 2026 |
| FMR LLC | 13,132,825 | 9.09% | Proxy statement (DEF 14A), table as of March 31, 2026 |
| RA Capital Management, L.P. | 12,974,599 | 8.99% | Schedule 13G, filed May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | 11,296,333 | 7.82% | Schedule 13G, filed February 17, 2026 |
| BlackRock | 10,971,816 | 7.60% | Form 13F, quarter ended March 31, 2026 |
| Wellington Management | 5,614,597 | 3.89% | Form 13F, quarter ended March 31, 2026 |
| State Street | 4,440,519 | 3.08% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 2,865,318 | 1.98% | Form 13F, quarter ended March 31, 2026 |
| Grant E. Pickering | 2,205,945 | 1.53% | Proxy statement (DEF 14A), table as of March 31, 2026 |
Percentages above are of 144,397,682 shares outstanding, as reported by Vaxcyte, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Vaxcyte, Inc.'s shareholder meeting held June 15, 2026, in the 2025-2026 proxy season, 349 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 2,507 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — Vaxcyte, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Vaxcyte, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 16, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Vaxcyte, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Vaxcyte, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Vaxcyte (PCVX) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/vaxcyte-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.